Precision Medicine Quarterly

Thermo Fisher Scientific Completes FDA Listing and Launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Use

2021-03-25T09:39:58-05:00March 25th, 2021|

Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug Administration (FDA) listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System. The innovative product enables clinical laboratories and assay developers to meet testing demands and enhance their molecular diagnostics workflows. Clinical diagnostic and hospital laboratories across the United States [...]

NeoGenomics Agrees to Acquire Trapelo Health

2021-03-25T06:22:20-05:00March 24th, 2021|

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today that it has agreed to acquire Intervention Insights, Inc. d/b/a Trapelo Health, an Information Technology company focused on precision oncology. The agreement purchase price of $65 million, consisting of $35 million in cash on hand and [...]

Scipher Medicine Announces $82 Million Financing

2021-03-24T08:10:05-05:00March 24th, 2021|

Scipher Medicine®, a precision immunology company matching patients with the most effective therapy, announced the completion of its Series C financing led by aMoon and Northpond Ventures, with participation from Echo Health Ventures and existing investors, Khosla Ventures and Alumni Ventures. To date, the company has raised $117 million. An estimated $630 billion is [...]

PrecisionLife continues growth and expansion with acquisition of Danish genomic analytics innovator GenoKey

2021-03-24T08:08:10-05:00March 24th, 2021|

PrecisionLife today announces that it has acquired its long-term Danish technology development partner GenoKey ApS, bringing together the leaders in combinatorial analytics and large-scale genomic analysis, and enabling PrecisionLife to continue its expansion as an AI-enabled precision medicine company. Financial details of the paper-based transaction were not disclosed. PrecisionLife’s platform, which includes technology developed [...]

Genomenon Completes $5.3M Financing Round

2021-03-17T08:53:11-05:00March 17th, 2021|

Genomenon announced that it has completed a $5.3M financing round in the company. The financing will enable the company to expand its commercial operations, which serve genetic testing labs, hospitals, pharmaceutical and biopharma companies. Genomenon leverages AI (Artificial Intelligence) to organize the world’s genomic knowledge and put it at the fingertips of doctors and [...]

Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer

2021-03-15T09:50:03-05:00March 15th, 2021|

Agilent Technologies Inc. (NYSE: A), has announced that Dr. Katharine (Kate) Knobil is joining Agilent as the company’s chief medical officer (CMO). The chief medical officer at Agilent is a newly created position designed to advise, lead, and elevate the company’s presence in the health-care industry. As Agilent’s first CMO, she will play a [...]

Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders

2021-03-15T09:40:18-05:00March 15th, 2021|

Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing methodology, an advanced genetic testing method currently used to diagnose rare inherited and neurological disorders. The series C funding round was led by GHS Fund (Quark Venture LP and GF [...]

Healthcare Executive Martha R. Temple Joins Coriell Life Sciences Board of Directors

2021-03-12T15:19:17-05:00March 12th, 2021|

As Coriell Life Sciences (CLS) delivers paths to better health and more efficient care through precision medicine, the organization welcomes Martha R. Temple, FSA to its Board of Directors. Temple most recently served as CEO of Optum Behavioral Health, part of UnitedHealth Group, and was previously President of the New England Market for Aetna. [...]

IDT Acquires Swift Biosciences

2021-03-11T12:53:55-05:00March 11th, 2021|

Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced today the acquisition of Swift Biosciences, a pioneer in the development of Next-Generation Sequencing (NGS) library preparation genomics kits for academic, translational, and clinical research. IDT is a leader in developing and manufacturing nucleic acid products for academic and commercial research, agriculture, medical [...]

Konica Minolta Precision Medicine collaborates with AWS to create the next generation of precision diagnostics

2021-03-11T12:00:11-05:00March 11th, 2021|

Konica Minolta Precision Medicine, Inc. (KMPM) announced today a five-year collaboration with Amazon Web Services, Inc. (AWS). As the Preferred Cloud Provider for KMPM, AWS will support the build-out of the company’s LATTICE™ initiative globally. LATTICE™ is a groundbreaking integrated diagnostic data platform that combines genomics, pathology, and radiology data along with other critical [...]

Go to Top